🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: FF, 200 mcg

Found 16 matching trials

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

PHASE2

This is a randomized, placebo-controlled, 2-period crossover, escalating re...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-02-09

Trial ID

NCT02991859

Treatments Being Tested

Fluticasone furoate (FF) Dry Powder Inhaler Fluticasone propionate (FP) Dry Powder Inhaler Budesonide (BUD) Turbuhaler Placebo (ELLIPTA or DISKUS)

A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma

PHASE3

A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...

Status

Completed

Location

GSK Investigational Site

Start Date

2016-10-13

Trial ID

NCT02924688

Treatments Being Tested

FF/UMEC/VI (100/31.25/25) mcg FF/UMEC/VI (100/62.5/25) mcg FF/UMEC/VI (200/31.25/25) mcg FF/UMEC/VI (200/62.5/25) mcg FF/VI (100/25) mcg FF/VI (200/25) mcg Fluticasone/salmeterol (FSC)Albuterol/salbutamol ELLIPTA DPI DISKUS DPI METERED-DOSE INHALER (MDI)

Fluticasone Nasal Spray Patient Preference Study

PHASE3

The objectives of this study are to evaluate and compare patient preference...

Status

Completed

Location

GSK Investigational Site

Start Date

2006-12-01

Trial ID

NCT00398476

Treatments Being Tested

fluticasone propionate (FP)fluticasone furoate (FF)

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.

PHASE3

This is a Phase III, multicenter, randomized, double-blind, stratified, par...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-09-20

Trial ID

NCT01686633

Treatments Being Tested

Fluticasone Furoate/ Vilanterol 200/25 mcg Fluticasone Furoate/ Vilanterol 100/25 mcg Fluticasone Furoate 100 mcg

Relovair PD PK in Chinese Healthy Subjects

PHASE1

In this study, fluticasone furoate (FF) and vilanterol (VI) in different do...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-12-05

Trial ID

NCT01711463

Treatments Being Tested

Fluticasone Furoate/Vilanterol Placebo

A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)

PHASE1

The purpose of this study is to demonstrate dose proportionality of the FF ...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-08-15

Trial ID

NCT01669070

Treatments Being Tested

FF, 50 mcg FF, 100 mcg FF, 200 mcg FF, 250 mcg

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

PHASE3

Despite availability of treatments and published guidelines, subjects may h...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-06-22

Trial ID

NCT03184987

Treatments Being Tested

FF/UMEC/VI 100/62.5/25 mcg FF/UMEC/VI 200/62.5/25 mcg Salbutamol ACQ-7

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

PHASE2

This study will be a randomised, double blind, placebo controlled, 3-way, i...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-10

Trial ID

NCT01957202

Treatments Being Tested

FF/levocabastine FF levocabastine Placebo

Corrected QT (QTc) Study With Flucticasone Furoate and GW642444

PHASE1

A randomised, placebo controlled thorough QTc study to evaluate the effect ...

Status

Completed

Location

GSK Investigational Site

Start Date

2010-06-23

Trial ID

NCT01209026

Treatments Being Tested

Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination Placebo Inhaler Moxifloxacin 400mg Moxifloxacin placebo

Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old

PHASE2

The rationale is to investigate the systemic availability of BDP/B17MP and ...

Status

Completed

Location

BorneAstmaKlinikken

Start Date

2009-09

Trial ID

NCT01848769

Treatments Being Tested

CHF1535 pMDI + AC Plus BDP + AC Plus Formoterol + AC Plus

Previous Next